PDS Biotechnology Corp reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Princeton, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
PDS Biotechnology Corp has filed 795 SEC EDGAR filings since 16 Sep 2009

SEC filing history

Showing 626-650 of 794 matching filings.

Per page
25
Current page
26
4

PRIMARY DOCUMENT

Filing date
10 Jul 2017
Reporting date
07 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Jul 2017
Reporting date
03 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37568

FORM 8-K

Filing date
06 Jul 2017
Reporting date
30 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Jun 2017
Reporting date
20 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Jun 2017
Reporting date
20 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Jun 2017
Reporting date
20 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Jun 2017
Reporting date
20 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Jun 2017
Reporting date
20 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Jun 2017
Reporting date
20 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Jun 2017
Reporting date
20 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37568

8-K

Filing date
21 Jun 2017
Reporting date
20 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37568

FORM 8-K

Filing date
09 Jun 2017
Reporting date
08 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
09 May 2017
Reporting date
26 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37568

8-K

Filing date
03 May 2017
Reporting date
03 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-37568

DEFA14A

Filing date
28 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-37568

DEF 14A

Filing date
28 Apr 2017
Reporting date
20 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89138

SCHEDULE 13G

Filing date
25 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37568

8-K

Filing date
19 Apr 2017
Reporting date
19 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-214196

424B5

Filing date
19 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37568

EDGE THERAPEUTICS, INC 8-K 3-13-2017 (RELEASE AGREEMENT)

Filing date
15 Mar 2017
Reporting date
13 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 Mar 2017
Reporting date
13 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 Mar 2017
Reporting date
13 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 Mar 2017
Reporting date
13 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 Mar 2017
Reporting date
13 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .